Treatment of vulnerable atherosclerotic plaques: the PREVENT trial

Lancet. 2024 Nov 9;404(10465):1810-1811. doi: 10.1016/S0140-6736(24)02220-7.

Authors

Giuseppe Ferrante¹, Gianluca Mincione², Antonio Colombo²

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Italy; Department of Cardiovascular Medicine, Humanitas Research Hospital-IRCCS, Rozzano, Italy. Electronic address: [email protected].
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Italy; Department of Cardiovascular Medicine, Humanitas Research Hospital-IRCCS, Rozzano, Italy.

PMID: 39521509
DOI: 10.1016/S0140-6736(24)02220-7

No abstract available

Publication types

Letter